The new reaction from the Baran lab can create complex “amines” that could be highly useful in pharmaceuticals, but have been impractical—or impossible—to make with standard methods.
The results from the Oldstone lab suggest that drugs blocking IFNβ might one day be used to treat persistent viral infections, which include those caused by HIV and hepatitis B and C infections.
A study from the Contet lab shows deleting a specific gene in mice ramps up alcohol consumption.
The project, led by Scripps Florida’s Anutosh Chakraborty, will explore a potential new drug target.